Cauldron Ferm
Provides continuous hyper-fermentation technology for industrial-scale bio-production
$13.3MSeries A2
Role not disclosedMS
Main Sequence Ventures
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Enterprise software · Jan 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $33.3M 2 disclosed · full round size, not this investor’s share